Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia (Q36984852)

17 August 2017

1 reference

title

Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia (English)

1 reference

17 August 2017

1 reference

1

Fielding AK

1 reference

17 August 2017

Goldstone AH

2

1 reference

PubMed ID

17968326

17 August 2017

language of work or name

English

0 references

publication date

29 October 2007

1 reference

Bone Marrow Transplantation

17 August 2017

1 reference

17 August 2017

41

1 reference

17 August 2017

5

1 reference

17 August 2017

447-453

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705904

17 August 2017

0 references

cites work

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Philadelphia positive acute lymphoblastic leukaemia of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705904

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705904

1 reference

17 August 2017

1 reference

PubMed ID

17968326